Vadim N. Gladyshev is a Professor of Medicine at Harvard Medical School, Director of the Center for Redox Medicine at Brigham and Women's Hospital, and faculty member of the Broad Institute. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation, and lifespan control using a combination of experimental and computational approaches. He has published more than 450 articles. Dr. Gladyshev is the recipient of NIH Pioneer, Transformative and Eureka awards and is an elected member of the National...
Vadim N. Gladyshev is a Professor of Medicine at Harvard Medical School, Director of the Center for Redox Medicine at Brigham and Women's Hospital, and faculty member of the Broad Institute. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation, and lifespan control using a combination of experimental and computational approaches. He has published more than 450 articles. Dr. Gladyshev is the recipient of NIH Pioneer, Transformative and Eureka awards and is an elected member of the National Academy of Sciences, USA. Gladyshev is known for his characterization of the human selenoproteome. He has studied the process of how organisms can acquire cellular damage from their food and the role selenium plays as a micro-nutrient with significant health benefits. In 2013, he won the National Institutes of Health Pioneer Award.
Gladyshev obtained his education at MSU. He completed his postdoctoral training under Dr. Thressa Stadtman of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and then with the Dolph L. Hatfield, National Cancer Institute (NCI).
Vadim N. Gladyshev is a Professor of Medicine at Harvard Medical School, Director of the Center for Redox Medicine at Brigham and Women's Hospital, and faculty member of the Broad Institute. Dr. Gladyshev’s lab focuses on studying aging, rejuvenation, and lifespan control using a combination of experimental and computational approaches. He has published more than 450 articles. Dr. Gladyshev is the recipient of NIH Pioneer, Transformative and Eureka awards and is an elected member of the National Academy of Sciences, USA. Gladyshev is known for his characterization of the human selenoproteome. He has studied the process of how organisms can acquire cellular damage from their food and the role selenium plays as a micro-nutrient with significant health benefits. In 2013, he won the National Institutes of Health Pioneer Award.
Gladyshev obtained his education at MSU. He completed his postdoctoral training under Dr. Thressa Stadtman of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), and then with the Dolph L. Hatfield, National Cancer Institute (NCI).
